2016 Oct 25
$2M gift to drive Weill Cornell advances in immunotherapy
Ellen and Gary Davis have generously made a $2 million gift to Weill Cornell Medicine to drive ongoing research in immunotherapy. Read more
2016 Oct 24
Precision medicine is more than genomic sequencing
There has been an overemphasis on the genomic component of precision medicine, according to Mark Rubin, M.D., director of the Englander Institute for Precision Medicine. Read more
2016 Oct 21
Researchers tackle metastatic breast cancer
Linda Vahdat, M.D., appeared on CBS News to discuss her novel copper depletion therapy for metastatic breast cancer. Read more
2016 Oct 20
Apostolou receives $1.5m NIH New Innovator Award
Eftychia Apostolou, Ph.D., has won a New Innovator Award from the National Institutes of Health for her research on how cells preserve their identity under normal conditions or alter it during pathogenesis Read more
2016 Oct 20
Brain surgeon chases new therapies for hard-to-treat tumors
Rohan Ramakrishna, M.D., is testing two innovative new therapies for recurrent glioblastoma and gliosarcoma. Read more
2016 Oct 20
Furman advises in CLL: Choose appropriate agents and focus on PFS endpoint
Richard Furman, M.D., shared insights into CLL treatments at a special session of the 2016 Annual ASH Meeting on Hematologic Malignancies. Read more
2016 Oct 19
Cold caps help breast cancer patients save their hair
A CBS News feature about cold cap therapy for breast cancer includes a Weill Cornell patient and Tessa Cigler, M.D. Read more
2016 Oct 19
Cryoablation: Freezing away breast cancers
Rache Simmons, M.D., discusses a new non-surgical deep-freezing treatment for breast cancer. Read more
2016 Oct 17
Study finds what could be a key to prostate cancer progression
Mark Rubin, M.D., discusses the findings of a study of DNA-repair gene mutations in predicting invasive prostate cancer. Read more
2016 Oct 17
Chemotherapy drives treatment resistance in bladder cancer
While chemotherapy kills the most common type of bladder cancer, urothelial cancer, it also shapes the genetic evolution of remaining urothelial cancer cell clones to become drug-resistant, according to Bishoy Faltas and colleagues. Read more
2016 Oct 10
Do I Have a Hidden Cancer?
A profile of Francis Barany, Ph.D., and some of his cancer detection tests. Read more
2016 Oct 10
Gene identified that drives aggressive prostate cancer
David Rickman, Ph.D., and colleagues have identified a gene that appears to regulate the change from prostate adenocarcinoma to neuroendocrine prostate cancer. Read more
2016 Oct 08
Alisertib may benefit certain patients with neuroendocrine prostate cancer
Alisertib monotherapy may be effective in certain patients with clinical or pathologically defined neuroendocrine prostate cancer, according to Himisha Beltran, M.D. Read more
2016 Oct 07
Chasing after ‘Compassionate Use’
Jeffrey Greenfield, M.D., Ph.D., speaks out about the need for wider - and speedier - use of the FDA compassionate use exception. Read more
2016 Oct 05
Pricey new treatment roils issues of how to treat prostate cancer
Drs. Jim Hu and Art Sedrakyan comment on the use of high-intensity focused ultrasound for prostate cancer treatment. Read more
2016 Sep 28
Weill Cornell, New York Genome Center Win NCI Grant to Support New TCGA Phase
A new collaboration will be formed to help further data analysis for the Cancer Genome Atlas project, thanks to a $490,000 grant from the National Cancer Institute. Read more
2016 Sep 28
Believe in Brooke: Finding peace with DIPG
A community has rallied around an 8-year-old with pediatric brain cancer, and the doctor who has saved her life so far with his experimental treatment. Read more
2016 Sep 28
Freezing technique is an effective alternative to lumpectomy for early stage breast cancer, study finds
A deep-freezing technique known as cryoablation is a viable alternative to traditional surgery in many early-stage breast cancers, according to Rache Simmons, M.D. Read more
2016 Sep 27
New drugs, immuno-oncology advances gastric cancer treatment paradigm
Immuno-oncology and the classification of subtypes of gastric cancer could greatly advance treatment efficacy and variation, according to Manish A. Shah, M.D. Read more
2016 Sep 26
Collaborative MDS research yields world-class results
The Weill Cornell Medicine Leukemia Program is part of collaborative research into myelodysplastic syndromes (MDS). Read more
